Published in Biol Cell on January 01, 1991
Cultured peripheral neuroglial cells are highly permissive to sheep prion infection. J Virol (2004) 1.19
Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans. Eukaryot Cell (2009) 1.17
Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide. Proc Natl Acad Sci U S A (1994) 1.05
Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. Proc Natl Acad Sci U S A (1998) 0.95
Modeling human endothelial cell transformation in vascular neoplasias. Dis Model Mech (2013) 0.89
An immortalized human blood-nerve barrier endothelial cell line for in vitro permeability studies. Cell Mol Neurobiol (2012) 0.89
Functional analysis of the human somatic angiotensin I-converting enzyme gene promoter. Biochem J (1993) 0.84
Protective effect of platelet activating factor antagonists on cultured endothelial cell lysis induced by elastase or activated neutrophils. Br J Pharmacol (1996) 0.75
A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet (1998) 4.75
Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell (1994) 3.01
Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol (2001) 2.06
Spatial and temporal patterns of c-kit-expressing cells in WlacZ/+ and WlacZ/WlacZ mouse embryos. Development (1996) 1.95
Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J Cell Biol (1997) 1.94
Polyoma virus T antigen. I. Synthesis of modified heat-labile T angiten in cells transformed with the ts-a mutant. J Virol (1975) 1.82
Cardiovascular lesions and skeletal myopathy in mice lacking desmin. Dev Biol (1996) 1.80
Desmin myopathy. Brain (2004) 1.79
Initial expression of neurofilaments and vimentin in the central and peripheral nervous system of the mouse embryo in vivo. J Neurosci (1984) 1.66
Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene. J Virol (1990) 1.64
Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab Invest (1997) 1.62
The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development (1996) 1.61
Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul Disord (1999) 1.45
Null mutation in the desmin gene gives rise to a cardiomyopathy. J Mol Cell Cardiol (1997) 1.44
Human monoclonal IgM with autoantibody activity against intermediate filaments. Proc Natl Acad Sci U S A (1982) 1.31
Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J Exp Med (2000) 1.31
Antibodies as probes of cellular differentiation and cytoskeletal organization in the mouse blastocyst. Exp Cell Res (1980) 1.27
A crucial role for Pax3 in the development of the hypaxial musculature and the long-range migration of muscle precursors. Dev Biol (1998) 1.26
Early segregation of a neuronal precursor cell line in the neural crest as revealed by culture in a chemically defined medium. Cell (1983) 1.26
Nucleotide sequence of the human vimentin gene and regulation of its transcription in tissues and cultured cells. Gene (1988) 1.24
Alteration of vimentin intermediate filament expression during differentiation of human hemopoietic cells. EMBO J (1983) 1.22
Vimentin gene: expression in human lymphocytes and in Burkitt's lymphoma cells. EMBO J (1986) 1.21
Genes occupy a fixed and symmetrical position on sister chromatids. Cell (1991) 1.20
Role of prolactin and glucocorticoids in the expression of casein genes in rabbit mammary gland organ culture. Quantification of casein mRNA. Biochim Biophys Acta (1978) 1.17
Human desmin-coding gene: complete nucleotide sequence, characterization and regulation of expression during myogenesis and development. Gene (1989) 1.13
The importance of intermediate filaments in the adaptation of tissues to mechanical stress: evidence from gene knockout studies. Biol Cell (1997) 1.13
Study of regulation of mitochondrial respiration in vivo. An analysis of influence of ADP diffusion and possible role of cytoskeleton. Biochim Biophys Acta (1997) 1.12
In vitro differentiation of mouse teratocarcinoma cells monitored by intermediate filament expression. Differentiation (1982) 1.10
Glial fibrillary acidic protein (GFAP): modulation by growth factors and its implication in astrocyte differentiation. Braz J Med Biol Res (1999) 1.10
Desmin sequence elements regulating skeletal muscle-specific expression in transgenic mice. Development (1993) 1.06
High level desmin expression depends on a muscle-specific enhancer. J Biol Chem (1991) 1.05
Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide. Proc Natl Acad Sci U S A (1994) 1.05
Induction of lactose synthesis by prolactin in rabbit mammary gland extracts. J Endocrinol (1972) 1.04
Activation of the human vimentin gene by the Tax human T-cell leukemia virus. I. Mechanisms of regulation by the NF-kappa B transcription factor. J Biol Chem (1993) 1.04
Assignment of human desmin gene to band 2q35 by nonradioactive in situ hybridization. Hum Genet (1989) 1.03
Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene. Neuromuscul Disord (2008) 1.02
Interaction of Theiler's virus with intermediate filaments of infected cells. J Virol (1998) 1.01
Purification of polyoma T antigen from transformed cells. Biochem Biophys Res Commun (1975) 1.00
Reorganization of the cytoskeleton by interferon in MSV-transformed cells. J Interferon Res (1981) 0.99
Different factors interact with myoblast-specific and myotube-specific enhancer regions of the human desmin gene. J Biol Chem (1993) 0.99
Immunochemical procedure for partial purification of newly synthesized proteins in polyoma virus-infected mouse cells. J Virol (1974) 0.98
Enzymatic hydrolysis of N-acyl-aminoacyl transfer RNAs. Cold Spring Harb Symp Quant Biol (1969) 0.97
Evidence for a polarity in the distribution of proteins from the cytoskeleton in Torpedo marmorata electrocytes. J Cell Biol (1986) 0.96
An overlapping CArG/octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells. Dev Biol (2000) 0.96
Human synemin gene generates splice variants encoding two distinct intermediate filament proteins. Eur J Biochem (2001) 0.96
The mouse synemin gene encodes three intermediate filament proteins generated by alternative exon usage and different open reading frames. Exp Cell Res (2004) 0.94
Hearts from mice lacking desmin have a myopathy with impaired active force generation and unaltered wall compliance. Cardiovasc Res (2002) 0.94
Tropomyosin synthesis accompanies formation of actin filaments in embryonal carcinoma cells induced to differentiate by hexamethylene bisacetamide. Proc Natl Acad Sci U S A (1979) 0.94
What can be learned from intermediate filament gene regulation in the mouse embryo. Int J Dev Biol (1995) 0.94
On-line pharmacokinetics of chloramphenicol in rat cortex by in vivo electrochemical detection. Chemotherapy (1984) 0.93
Effects of desmin gene knockout on mice heart mitochondria. J Bioenerg Biomembr (2001) 0.93
Long-term secretion of therapeutic proteins from genetically modified skeletal muscles. Hum Gene Ther (1996) 0.93
Nestin is expressed during development and in myotendinous and neuromuscular junctions in wild type and desmin knock-out mice. Exp Cell Res (1999) 0.93
Human desmin gene: cDNA sequence, regional localization and exclusion of the locus in a familial desmin-related myopathy. Hum Genet (1996) 0.92
Mechanical alterations in smooth muscle from mice lacking desmin. J Muscle Res Cell Motil (1998) 0.92
PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells. Oncogene (1996) 0.92
Differences in the distribution of synemin, paranemin, and plectin in skeletal muscles of wild-type and desmin knock-out mice. Histochem Cell Biol (2000) 0.91
Identification of a negative element in the human vimentin promoter: modulation by the human T-cell leukemia virus type I Tax protein. Mol Cell Biol (1993) 0.91
Human immortalized brown adipocytes express functional beta3-adrenoceptor coupled to lipolysis. J Cell Sci (1997) 0.91
Lower active force generation and improved fatigue resistance in skeletal muscle from desmin deficient mice. J Muscle Res Cell Motil (2003) 0.91
Sex-related differences in the developmental rate of in-vitro matured/in-vitro fertilized ovine embryos. Hum Reprod (1996) 0.91
Transplacental passage of vancomycin during the second trimester of pregnancy. Obstet Gynecol (1991) 0.91
Stabilization of casein mRNA by prolactin and glucocorticoids. Biochimie (1978) 0.90
Lack of desmin results in abortive muscle regeneration and modifications in synaptic structure. Cell Motil Cytoskeleton (2001) 0.90
Lactogenesis induced by ovariectomy in pregnant rats and its regulation by oestrogen and progesterone. J Steroid Biochem (1983) 0.90
[Familial myopathy with desmin storage seen as a granulo-filamentar, electron-dense material with mutation of the alphaB-cristallin gene]. Rev Neurol (Paris) (2000) 0.90
Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins. J Biol Chem (1992) 0.90
Desmin filaments influence myofilament spacing and lateral compliance of slow skeletal muscle fibers. Biophys J (2004) 0.90
Different expression of synemin isoforms in glia and neurons during nervous system development. Glia (2006) 0.89
Absence of desmin slightly prolongs myoblast proliferation and delays fusion in vivo in regenerating grafts of skeletal muscle. Cell Tissue Res (2001) 0.89
[Peptidyl-tRNA hydrolase: demonstration in various organisms. Enzymatic activity in the presence of ribosomes]. Biochimie (1971) 0.89
Myotube driven myogenic recruitment of cells during in vitro myogenesis. Dev Dyn (1995) 0.88
SV40 large T antigen interferes with adult myosin heavy chain expression, but not with differentiation of human satellite cells. Exp Cell Res (1996) 0.88
Cefsulodin penetration into rat brain: extracellular versus total concentration. Chemotherapy (1986) 0.88
Targeting widespread sites of damage in dystrophic muscle: engrafted macrophages as potential shuttles. Gene Ther (1996) 0.88
Mechanical properties and structure of carotid arteries in mice lacking desmin. Cardiovasc Res (2001) 0.88
Immortalization of multiple cell types from transgenic mice using a transgene containing the vimentin promoter and a conditional oncogene. Exp Cell Res (1994) 0.88
Cell adhesion markers are expressed by a stable human endothelial cell line transformed by the SV40 large T antigen under vimentin promoter control. J Cell Physiol (1993) 0.87
Control by the extracellular environment of differentiation pathways in 1003 embryonal carcinoma cells: study at the level of specific intermediate filaments. EMBO J (1982) 0.87
Desmin-lacZ transgene expression and regeneration within skeletal muscle transplants. J Muscle Res Cell Motil (1997) 0.86
Inhibition by progesterone of the lactogenic effect of prolactin in the pseudopregnant rabbit. Biochem J (1974) 0.86
Neurons induce GFAP gene promoter of cultured astrocytes from transgenic mice. Glia (1999) 0.86
Chimeric smooth muscle-specific enhancer/promoters: valuable tools for adenovirus-mediated cardiovascular gene therapy. Circ Res (2001) 0.86
Unusual organization of desmin intermediate filaments in muscular dysgenesis and TTX-treated myotubes. Dev Biol (1988) 0.86
Pharmacokinetics and protein binding of ceftriaxone during pregnancy. Antimicrob Agents Chemother (1993) 0.86
Post-transcriptional stimulation of casein synthesis by thyroid hormone. Biochimie (1978) 0.85
Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses. Virology (1999) 0.85
Chromosomal localization of the mouse gene coding for vimentin. Genet Res (1989) 0.85
Cytoskeleton organization in differentiating mouse teratocarcinoma cells. Biochimie (1981) 0.85
A 28-bp negative element with multiple factor-binding activity controls expression of the vimentin-encoding gene. Gene (1996) 0.85
Induction of blood-brain barrier differentiation in a rat brain-derived endothelial cell line. Exp Cell Res (1995) 0.85
Differences in sulfation patterns of heparan sulfate derived from human bone marrow and umbilical vein endothelial cells. Exp Hematol (2001) 0.84